Correction to Lancet Infect Dis 2017; 17: 804–05

IF 36.4 1区医学 Q1 INFECTIOUS DISEASES

Lancet Infectious Diseases Pub Date : 2025-03-12 DOI:10.1016/s1473-3099(25)00167-7

引用次数: 0

Abstract

Raoult D, Abat C. Developing new insecticides to prevent chaos: the real future threat. Lancet Infect Dis 2017; 17: 804–05—The declaration of interests section of this Correspondence has been updated to add a competing interest and now reads ‘DR is a founder of Arthrobac Pharma. CA declares no competing interests.’ The authors of the article have been contacted about the correction and have not replied. This correction has been made as of March 12, 2025.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Lancet Infectious Diseases 医学-传染病学

CiteScore

60.90

自引率

0.70%

发文量

1064

审稿时长

6-12 weeks

期刊介绍： The Lancet Infectious Diseases was launched in August, 2001, and is a lively monthly journal of original research, review, opinion, and news covering international issues relevant to clinical infectious diseases specialists worldwide.The infectious diseases journal aims to be a world-leading publication, featuring original research that advocates change or sheds light on clinical practices related to infectious diseases. The journal prioritizes articles with the potential to impact clinical practice or influence perspectives. Content covers a wide range of topics, including anti-infective therapy and immunization, bacterial, viral, fungal, and parasitic infections, emerging infectious diseases, HIV/AIDS, malaria, tuberculosis, mycobacterial infections, infection control, infectious diseases epidemiology, neglected tropical diseases, and travel medicine. Informative reviews on any subject linked to infectious diseases and human health are also welcomed.